Face Mask Use and Chalazion Procedures Over 8 Years of US Medicare Data

References

[1] M. Mackwood, E. Fisher, R. O. Schmidt, et al., “Changes in US Primary Care Access and Capabilities During the COVID-19 Pandemic,” JAMA Health Forum 6, no. 2 (2025): e245237–e245237.

[2] E. S. Kim, E. E. Afshin, and E. Elahi, “The Lowly Chalazion,” Survey of Ophthalmology 68, no. 4 (2023): 784–793.

[3] R. Z. Silkiss, M. K. Paap, and S. Ugradar, “Increased Incidence of Chalazion Associated With Face Mask Wear During the COVID-19 Pandemic,” American Journal of Ophthalmology Case Reports 22 (2021): 101032.

[4] W. Akioud, S. Sebbata, Y. Mozarie, and A. Oubaaz, “Chalazion and Face Mask Wear During COVID-,” European Journal of Medical and Health Sciences 5, no. 2 (2023): 19.

[5] J. Coblentz, M. Arruda, H. Nogueira, A. Fajardo, K. Ozdemir, and M. Burnier, “The Increasing Number of Surgically Excised Chalazion During the COVID-19 Pandemic,” The Pan-American Journal of Ophthalmology 6, no. 1 (2024): 61.

[6] M. Moshirfar, W. B. West, and D. P. Marx, “Face Mask-Associated Ocular Irritation and Dryness,” Ophthalmology and Therapy 9, no. 3 (2020): 397–400.

[7] A. Y. Nemet, S. Vinker, and I. Kaiserman, “Associated Morbidity of Chalazia,” Cornea 30, no. 12 (2011): 1376–1381.

[8] G. Giannaccare, S. Vaccaro, A. Mancini, and V. Scorcia, “Dry Eye in the COVID-19 Era: How the Measures for Controlling Pandemic Might Harm Ocular Surface,” Graefe's Archive for Clinical and Experimental Ophthalmology 258, no. 11 (2020): 2567–2568.

[9] B. Burgos-Blasco, P. Arriola-Villalobos, J. I. Fernandez-Vigo, et al., “Face Mask Use and Effects on the Ocular Surface Health: A Comprehensive Review,” Ocular Surface 27 (2022): 56.

[10] V. A. Koshevarova, Z. K. Westenhaver, M. Schmitz-Brown, B. J. McKinnon, K. H. Merkley, and P. K. Gupta, “Blepharoconjunctivitis and Otolaryngological Disease Trends in the Context of Mask Wearing During the COVID-19 Pandemic,” Clinics and Practice 12, no. 4 (2022): 619–627.

[11] G. Visioli, M. P. Pirraglia, A. Lambiase, and M. Gharbiya, “Misleading Citations and Publication Bias in COVID-19 in Ophthalmology,” Journal of Evidence-Based Medicine 17, no. 4 (2024): 703–704.

[12] V. Fung, R. J. Brand, J. P. Newhouse, and J. Hsu, “Using Medicare Data for Comparative Effectiveness Research—Opportunities and Challenges,” American Journal of Managed Care 17, no. 7 (2011): 488.

Rights & permissions

2026 The Author(s). Journal of Evidence-Based Medicine published by Chinese Cochrane Center, West China Hospital of Sichuan University and John Wiley & Sons Australia, Ltd.